- Home
- STIM vs PLMK Comparison
STIM vs PLMK Comparison
Compare STIM & PLMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- PLMK
- Stock Information
- Founded
- STIM 2003
- PLMK 2024
- Country
- STIM United States
- PLMK United States
- Employees
- STIM N/A
- PLMK N/A
- Industry
- STIM Medical/Dental Instruments
- PLMK
- Sector
- STIM Health Care
- PLMK
- Exchange
- STIM Nasdaq
- PLMK NYSE
- Market Cap
- STIM 232.3M
- PLMK 241.7M
- IPO Year
- STIM 2018
- PLMK 2025
- Fundamental
- Price
- STIM $4.43
- PLMK $10.13
- Analyst Decision
- STIM Buy
- PLMK
- Analyst Count
- STIM 4
- PLMK 0
- Target Price
- STIM $6.00
- PLMK N/A
- AVG Volume (30 Days)
- STIM 792.7K
- PLMK 231.1K
- Earning Date
- STIM 05-06-2025
- PLMK 01-01-0001
- Dividend Yield
- STIM N/A
- PLMK N/A
- EPS Growth
- STIM N/A
- PLMK N/A
- EPS
- STIM N/A
- PLMK N/A
- Revenue
- STIM $89,448,000.00
- PLMK N/A
- Revenue This Year
- STIM $102.36
- PLMK N/A
- Revenue Next Year
- STIM $9.83
- PLMK N/A
- P/E Ratio
- STIM N/A
- PLMK N/A
- Revenue Growth
- STIM 22.16
- PLMK N/A
- 52 Week Low
- STIM $0.52
- PLMK $9.94
- 52 Week High
- STIM $5.92
- PLMK $10.19
- Technical
- Relative Strength Index (RSI)
- STIM 54.83
- PLMK N/A
- Support Level
- STIM $3.30
- PLMK N/A
- Resistance Level
- STIM $4.82
- PLMK N/A
- Average True Range (ATR)
- STIM 0.32
- PLMK 0.00
- MACD
- STIM 0.03
- PLMK 0.00
- Stochastic Oscillator
- STIM 74.59
- PLMK 0.00
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About PLMK PLUM ACQUISITION CORP IV
Plum Acquisition Corp IV is a blank check company.